http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014072245-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb83c388f1991f565ee08d581db493d1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
| filingDate | 2013-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d0d9221a2707920d1a1e3c3f1d15e30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4110ba61a11aab1ab90fa49f4e15ae9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af3558d7670b4ae1562f736f922fd8fb |
| publicationDate | 2014-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014072245-A1 |
| titleOfInvention | Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation |
| abstract | Based on specific experimental studies the invention relates to an optimized levonorgestrel-only-composition for improved continuous oral contraception with consequences for suitable pharmaceutical preparations for the same purpose and with defined levonorgestrel content. The invention relates to a pharmaceutical composition for oral contraception for a woman of fertile age consisting of a number of separately packed and individually removable daily dosage units intended for consecutive daily oral administration, each dosage unit consisting of 60 to 100 mug of levonorgestrel and one or more pharmaceutical acceptable carriers and excipients. Additionally, the invention relates to a dosage regimen, i.e. to the use of an oral dosage form consisting of 60 to 100 mug of levonorgestrel and one or more pharmaceutical acceptable carriers and excipients per dosage unit for oral contraception for a woman of fertile age by administering one dosage unit daily during the complete menstruation cycle. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679114-B2 |
| priorityDate | 2012-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.